1. Home
  2. |Insights
  3. |Help Wanted: Bounty Hunters

Help Wanted: Bounty Hunters

Client Alert | less than 1 min read | 03.22.10

In a memorandum dated March 10, 2010, President Obama directed the heads of all executive departments and agencies to expand their use of recovery audits, now called “Payment Recapture Audits,” in order to identify and reclaim from contractors the funds associated with improper payments (e.g., duplicate payments, payments for services not rendered, overpayments, and payments to fictitious vendors) and has also directed OMB to develop guidance within 90 days for carrying out the requirements of the memorandum. He points approvingly to use of professional and specialized auditors whose compensation is tied to their findings of such overpayments.

Insights

Client Alert | 7 min read | 09.14.26

AI in Life Sciences: Ten Legal Considerations and Risks of AI Use in Drug Discovery and Development

Over the past several years, the biopharmaceutical industry has embraced artificial intelligence and machine learning (AI/ML) in near lockstep with the pace of AI/ML innovations. Today, industry leaders are using AI/ML to, among other things: discover and assess biological pathways, target chemical structures and sequences; design proteins; model pre-clinical and clinical trials; recruit and screen potential patient populations; evaluate clinical trial results and biomarker data; prepare regulatory filings; and manage supply chains. Deployment of new AI/ML models promises extraordinary advances in pharmaceutical development. However, as with any technological and scientific advances, the use of AI/ML also poses substantial legal risks that life sciences companies need to consider and proactively manage. ...

View All Insights